4.2 Article

Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Ophthalmology

Genetic associations of anti-vascular endothelial growth factor therapy response in age-related macular degeneration: a systematic review and meta-analysis

Zilin Wang et al.

Summary: The study identified 9 single-nucleotide polymorphisms in 4 genes that were associated with the anti-VEGF therapy response in AMD patients, indicating potential clinically useful biomarkers. Further research with diverse ethnicities and larger sample sizes is needed to strengthen the evidence.

ACTA OPHTHALMOLOGICA (2022)

Review Biochemistry & Molecular Biology

Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy

Yanhui Deng et al.

Summary: Age-related macular degeneration (AMD) is a complex eye disorder that leads to incurable blindness in the elderly, with wet and dry forms classified as the advanced stages. Genetic factors, lipid metabolism, oxidative stress, and aging all play a role in the development of AMD, with current treatment focusing on anti-VEGF therapy for wet AMD. New AMD drugs and iPSC-derived RPE cell therapy show promise in improving AMD treatment in the near future.

GENES & DISEASES (2022)

Review Biochemistry & Molecular Biology

The complement system in age-related macular degeneration

Angela Armento et al.

Summary: Age-related macular degeneration (AMD) is a complex disease with genetic, aging, and lifestyle factors all playing a role in its onset and progression. Therapeutic attempts targeting the complement system have not been successful, highlighting the complexity of AMD beyond genetic factors.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Medicine, General & Internal

Age-related macular degeneration

Monika Fleckenstein et al.

Summary: Age-related macular degeneration (AMD) is the leading cause of legal blindness in the industrialized world, with a complex pathophysiology involving aging, environmental factors, and genetic susceptibility leading to photoreceptor degeneration and drusen formation. Tailoring therapeutics to specific phenotypes and stages may be crucial for preventing irreversible vision loss in the future.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Medicine, Research & Experimental

Autophagy: A new insight into pathogenesis and treatment possibilities in age-related macular degeneration

Agnieszka Kubicka-Trzska et al.

POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2020)

Article Multidisciplinary Sciences

Loss of Complement Factor H impairs antioxidant capacity and energy metabolism of human RPE cells

Angela Armento et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration

Emilie Grarup Jensen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

The Role of Inflammation in Age-Related Macular Degeneration

Wei Tan et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Review Chemistry, Medicinal

Complement system and age-related macular degeneration: drugs and challenges

Jiali Wu et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Review Immunology

The Challenges and Promise of Complement Therapeutics for Ocular Diseases

Dong Ho Park et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Ophthalmology

Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept

Chikako Hara et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)

Article Biochemistry & Molecular Biology

Association Between Complement Factor C2/C3/CFB/CFH Polymorphisms and Age-Related Macular Degeneration: A Meta-Analysis

Feiteng Lu et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)

Article Medicine, Research & Experimental

VEGF regulates local inhibitory complement proteins in the eye and kidney

Lindsay S. Keir et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Review Biochemistry & Molecular Biology

Genetics of age-related macular degeneration (AMD)

Margaret M. DeAngelis et al.

HUMAN MOLECULAR GENETICS (2017)

Review Genetics & Heredity

Age-related macular degeneration: genome-wide association studies to translation

James R. M. Black et al.

GENETICS IN MEDICINE (2016)

Review Chemistry, Medicinal

Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review

Shiqi Yang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2016)

Review Genetics & Heredity

AMD and the alternative complement pathway: genetics and functional implications

Perciliz L. Tan et al.

HUMAN GENOMICS (2016)

Article Ophthalmology

Defining response to anti-VEGF therapies in neovascular AMD

W. M. Amoaku et al.

Review Biochemistry & Molecular Biology

Age-related macular degeneration and the role of the complement system

Selina McHarg et al.

MOLECULAR IMMUNOLOGY (2015)

Article Ophthalmology

Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy

S. Scott Whitmore et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2015)

Article Ophthalmology

Sudden Visual Deterioration as the First Symptom of Chronic Kidney Failure

Weronika Pociej-Marciak et al.

CASE REPORTS IN OPHTHALMOLOGY (2015)

Article Ophthalmology

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010

Rupert R. A. Bourne et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2014)

Article Ophthalmology

VEGF Gene Polymorphism and Response to Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration

Carlos Eduardo dos Reis Veloso et al.

OPHTHALMIC RESEARCH (2014)

Review Ophthalmology

Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration

Robert P. Finger et al.

SURVEY OF OPHTHALMOLOGY (2014)

Review Ophthalmology

Age-Related Macular Degeneration: Insights into Inflammatory Genes

Raffaella Cascella et al.

JOURNAL OF OPHTHALMOLOGY (2014)

Article Genetics & Heredity

Seven new loci associated with age-related macular degeneration

Lars G. Fritsche et al.

NATURE GENETICS (2013)

Article Ophthalmology

Clinical Classification of Age-related Macular Degeneration

Frederick L. Ferris et al.

OPHTHALMOLOGY (2013)

Review Ophthalmology

Smoking and Age-Related Macular Degeneration: Review and Update

Sara Velilla et al.

JOURNAL OF OPHTHALMOLOGY (2013)

Editorial Material Ophthalmology

Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?

Susanne Binder

BRITISH JOURNAL OF OPHTHALMOLOGY (2012)

Letter Ophthalmology

Resistance, not tachyphylaxis or tolerance

Olli Arjamaa et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2012)

Article Public, Environmental & Occupational Health

Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype

Reecha Sofat et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)

Article Ophthalmology

C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration

Imran A. Bhutto et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2011)

Article Multidisciplinary Sciences

Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement

Tommi Kajander et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Ophthalmology

Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD

Barbara Kloeckener-Gruissem et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)

Review Cell Biology

Complement and its role in innate and adaptive immune responses

Jason R. Dunkelberger et al.

CELL RESEARCH (2010)

Review Immunology

Complement: a key system for immune surveillance and homeostasis

Daniel Ricklin et al.

NATURE IMMUNOLOGY (2010)

Article Ophthalmology

Complement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration

Dimitra I. Marioli et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)

Article Ophthalmology

Polymorphisms of Complement Factor Genes and Age-Related Macular Degeneration in a German Population

H. Baatz et al.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2009)

Article Biochemistry & Molecular Biology

Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration

Kylee L. Spencer et al.

HUMAN MOLECULAR GENETICS (2007)

Article Multidisciplinary Sciences

Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid

P. T. Johnson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Ophthalmology

The genetics of age-related macular degeneration: A review of progress to date

Stephen Haddad et al.

SURVEY OF OPHTHALMOLOGY (2006)

Article Multidisciplinary Sciences

Complement factor H polymorphism in age-related macular degeneration

RJ Klein et al.

SCIENCE (2005)